NTLA icon

Intellia Therapeutics
NTLA

Overview Fund Activity

302 hedge funds and large institutions have $2.69B invested in Intellia Therapeutics in 2022 Q4 according to their latest regulatory filings, with 49 funds opening new positions, 119 increasing their positions, 80 reducing their positions, and 60 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
302
Holders Change
-16
Holders Change %
-5.03%
% of All Funds
4.87%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
49
Increased
119
Reduced
80
Closed
60
Calls
$22.8M
Puts
$11.7M
Net Calls
+$11.1M
Net Calls Change
+$803K

Top Buyers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$69.6M
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$272M
3
BlackRock
3
BlackRock
New York
$253M
4
State Street
4
State Street
Massachusetts
$131M
5
Morgan Stanley
5
Morgan Stanley
New York
$87.9M

Top Sellers

1
PHS
1
PFM Health Sciences
California
$0
2
APM
2
Avidity Partners Management
Texas
$22.3M
3
Goldman Sachs
3
Goldman Sachs
New York
$21.9M
4
Millennium Management
4
Millennium Management
New York
$1.75M
5
Connor, Clark & Lunn Investment Management (CC&L)
5
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
FCA
351
FinTrust Capital Advisors
South Carolina
– -$6K -100 Closed
SWM
352
Stapp Wealth Management
Washington
– -$6K -100 Closed
BFEC
353
Benjamin F. Edwards & Company
Missouri
– -$6K -100 Closed
HI
354
Hoey Investments
Pennsylvania
– -$6K -100 Closed
CWM
355
Castle Wealth Management
Florida
– -$3K -50 Closed
AF
356
Allworth Financial
California
– -$2K -33 Closed
HI
357
Hudock Inc
Pennsylvania
– -$1K -25 Closed
EI
358
Ellevest Inc
New York
– -$1K -21 Closed
BWL
359
Bogart Wealth LLC
Virginia
– -$1K -10 Closed
11 12 13 14
15